INS and diabetes mellitus: A total of 34 (35.8%) patients were treated with insulin, with no significant differences between groups (CaHMB Diabetes ONS: 12 (27.3%) patients; Diabetes-Specific ONS: 22 (43.1%) patients; p = 0.11).